TRAZIMERA

Powder for concentrate for solution for infusion, 420mg
RxActive license

Active substance (INN)

trastuzumab

Pharmaceutical form

Pharmaceutical formPowder for concentrate for solution for infusion
Strength420mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerPfizer Manufacturing Belgium NV, Belgium
Therapeutic groupAntineoplastic and immunomodulating agents (L01FD01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateNovember 5, 2021

Analogs in Montenegro

2

Other medicines with the same active substance

Source: CInMED register